Abbott Libre Rio
Over-the-counter glucose system announced for adults with type 2 diabetes who do not use insulin.
Keep in mind FDA clearance is not proof of released sales. Lingo and Libre-family specifications are not substituted.
Compare wearables
Compare up to 10 devices across categories. Keep the purpose and the source beside the numbers.
Search & choose modelsAdd models to your comparison
Build your comparison
2 / 10 models676 models available. Showing nine - search to narrow the list.
Comparison settingsMarket, sorting & differences
How price order works
Lowest recorded store prices take priority over announced or launch prices, within the selected source market. Currencies use the dated EUR reference rates. Deposits and recurring charges are excluded from price order; missing prices stay last. Original price records remain visible.
At a glance
The differences that matter
Eversense 365
Prescription continuous glucose monitoring for adults 18+ with diabetes.
Keep in mind Manufacturer specifications; no hands-on testing or independent clinical efficacy assessment.
Published specifications and documented constraints. See the full comparison below for prices and sources.
Scroll across the table to compare every model
| Biosensors & healthAdd a model |  |  |
|---|---|---|
| Prices · all markets | Price not verified 0 offer records & sourcesNo verified price in this audit. | Price not verified 0 offer records & sourcesNo verified price in this audit. |
| Designed for | Over-the-counter glucose system announced for adults with type 2 diabetes who do not use insulin. ↗ | Prescription continuous glucose monitoring for adults 18+ with diabetes. ↗ |
| Form factor | Continuous glucose biosensor ↗ | Provider-inserted upper-arm sensor with removable external transmitter ↗ |
| Water / dust rating | Not verified | One metre for up to 30 minutes ↗ |
| Measurement | Interstitial glucose monitoring ↗ | Not applicable to this category |
| Intended Users | Adults 18+ with type 2 diabetes, not using insulin ↗ | Not applicable to this category |
| USRegulatory | FDA OTC iCGM clearance announced June 2024 ↗ | Not applicable to this category |
| Interface | CGM system for glucose-pattern review ↗ | Not applicable to this category |
| Sensor Duration | Not applicable to this category | Up to 365 days ↗ |
| Reading interval | Not applicable to this category | Every five minutes ↗ |
| Transmitter Mount | Not applicable to this category | Daily-replaced silicone-based adhesive ↗ |
| Alerts | Not applicable to this category | On-body vibration and phone alerts ↗ |
| Calibration | Not applicable to this category | Once weekly after day 13; additional instructions apply ↗ |
| Placement | Not applicable to this category | Upper arm; trained healthcare-provider insertion/removal ↗ |
| Availability | Official 2024 clearance announcement confirmed; no current exact Libre Rio retail launch or price verified. | Exact manufacturer model verified; market and purchase eligibility follow the linked manufacturer source. |
| Important context |
|
|
| Editorial pick & release | No editorial ranking recorded | #10 · Our Top 10 Health sensors and monitoringRelease date not verifiedDocumented product in the stated source market; destination availability and checkout not tested. |
| Evidence | Manufacturer source Checked 2026-10-13 | Manufacturer source Checked 2026-10-12 |
Battery claims use different conditions and are not a controlled benchmark. “Not verified” is an evidence gap, not a missing feature. Prices are dated regional snapshots. Deposits, bundles and historical launch prices are labelled. Brightness measurement methods and battery workloads vary by manufacturer.